132 Cases of Contact Dermatitis due to Topical Corticosteroids Application Reported in Japan.

1995 ◽  
Vol 57 (5) ◽  
pp. 929-933
Author(s):  
Hidezo FUKUDA ◽  
Shuhei IMAYAMA
2013 ◽  
Vol 104 (1) ◽  
pp. 90-92
Author(s):  
E. Gómez de la Fuente ◽  
M. Andreu-Barasoain ◽  
A. Nuño-González ◽  
J.L. López-Estebaranz

1986 ◽  
Vol 24 (15) ◽  
pp. 57-59

Recent issues of the Monthly Index of Medical Specialities (MIMS) include a table (in section 13H) which lists some potential sensitisers in topical corticosteroid preparations. Such a list is valuable since allergic contact dermatitis due to a constituent of a topical preparation is a troublesome and avoidable cause of failure to respond. It should help in choosing preparations for a patient known to be sensitised to any of the compounds listed, and in avoiding the more common sensitisers.


1983 ◽  
Vol 9 (6) ◽  
pp. 470-478 ◽  
Author(s):  
A. Dooms-Goossens ◽  
J. Vanhee ◽  
D. Vanderheyden ◽  
D. Gevers ◽  
L. Willems ◽  
...  

1989 ◽  
Vol 21 (2) ◽  
pp. 83-91 ◽  
Author(s):  
Giampiero Rivara ◽  
Roland R. Tomb ◽  
Jean Foussereau

2021 ◽  
Vol 7 (2) ◽  
pp. 120-124
Author(s):  
Dhiraj Dhoot ◽  
R D Kharkar ◽  
Harshal Mahajan ◽  
Hanmant Barkate

Contact dermatitis is one the commonest dermatological condition which is managed by topical corticosteroids. Mid potent topical corticosteroids are commonly prescribed but there is no any comparative data between mometasone furoate and fluticasone propionate in the management of dermatitis.A real world retrospective study was conducted across India to compare the clinical assessment of mometasone 0.1% cream and fluticasone 0.005% cream in the management of contact dermatitis at 236 dermatology clinics.A data of 1106 patients were included in this analysis in which 598 were included in mometasone group while 508 in fluticasone group. At the end of 2 weeks, 216 patients (36.1%) in mometasone and 129 patients (25.4%) in fluticasone group achieved complete clearance of symptoms (p<0.05). Additionally, in mometasone group, 354 patients (59.2%) were found to achieve improvement whereas 293 patients (57.7%) achieved the same in fluticasone group. On further sub group analysis on aggravating factors, it was found that, mometasone was statistically significant in relieving symptoms of dermatitis due to artificial jewellery, detergent and occlusive foot ware than fluticasone. Moreover, mometasone demonstrated significant results in physician and patient global assessment as well. Patients in both groups tolerated therapy well.Both, mometasone furoate and fluticasone propionate were effective and safe in treatment of eczema/dermatitis. But mometasone furoate had shown significantly better effectiveness as compared to fluticasone in all predisposing factors for the disease.


Sign in / Sign up

Export Citation Format

Share Document